An inter-laboratory study to evaluate the effects of medium composition on the differentiation and barrier function of Caco-2 cell lines

被引:99
作者
Zucco, F
Batto, AF
Bises, G
Chambaz, J
Chiusolo, A
Consalvo, R
Cross, H
Dal Negro, G
de Angelis, I
Fabre, G
Guillou, F
Hoffman, S
Laplanche, L
Morel, E
Pinçon-Raymond, M
Prieto, P
Turco, L
Ranaldi, G
Rousset, M
Sambuy, Y
Scarino, ML
Torreilles, F
Stammati, A
机构
[1] Ist Super Sanita, Environm & Primary Prevent Dept, Mech Tox Unit, I-00161 Rome, Italy
[2] CNR, Ist Neurobiol & Med Mol, Rome, Italy
[3] Inst Biomed Cordeliers, INSERM, U505, UPMC, Paris, France
[4] Med Univ Vienna, Dept Pathophysiol, Vienna, Austria
[5] GlaxoSmithKline Inc, Verona, Italy
[6] ISt Nazl Ric Alimenti & Nutr, Rome, Italy
[7] Sanofi Synthelabo Res, Montpellier 4, France
[8] European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect, ECVAM, Ispra, Italy
来源
ATLA-ALTERNATIVES TO LABORATORY ANIMALS | 2005年 / 33卷 / 06期
关键词
barrier integrity; Caco-2; defined medium; epithelial differentiation; permeability; protocol standardisation;
D O I
10.1177/026119290503300618
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Differentiated human intestinal Caco-2 cells are frequently used in toxicology and pharmacology as in vitro models for studies on intestinal barrier functions. Since several discrepancies exist among the different lines and clones of Caco-2 cells, comparison of the results obtained and optimisation of models for use for regulatory purposes are particularly difficult, especially with respect to culture conditions and morphological and biochemical parameters. An inter-laboratory study has been performed on the parental cell line and on three clonal Caco-2 cell lines, with the aim of standardising the culture conditions and identifying the best cell line with respect to parameters relevant to barrier integrity, namely, trans-epithelial electrical resistance (TEER) and mannitol passage, and of epithelial differentiation (alkaline phosphatase activity). Comparison of the cell lines maintained in traditional serum-supplemented culture medium or in defined medium, containing insulin, transferrin, selenium and lipids, showed that parameter performance was better and more reproducible with the traditional medium. The maintenance of the cell lines for 15 days in culture was found to be sufficient for the development of barrier properties, but not for full epithelial differentiation. Caco-2/TC7 cells performed better than the other three cell lines, both in terms of reproducibility and performance, exhibiting low TEER and mannitol passage, and high alkaline phosphatase activity.
引用
收藏
页码:603 / 618
页数:16
相关论文
共 37 条
[1]  
[Anonymous], 2001, White Paper: Strategyfor afuture Chemicals
[2]   Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43
[3]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .1. A MODEL FOR STUDYING THE PASSIVE DIFFUSION OF DRUGS OVER INTESTINAL ABSORPTIVE (CACO-2) CELLS [J].
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (06) :476-482
[4]   Drug absorption studies of prodrug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transport [J].
Augustijns, P ;
Annaert, P ;
Heylen, P ;
Van den Mooter, G ;
Kinget, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 166 (01) :45-53
[5]  
BALLS M, 1995, ATLA-ALTERN LAB ANIM, V23, P129
[6]   SUBSTRATE-SPECIFICITY AND SOME PROPERTIES OF PHENOL SULFOTRANSFERASE FROM HUMAN INTESTINAL CACO-2 CELLS [J].
BARANCZYKKUZMA, A ;
GARREN, JA ;
HIDALGO, IJ ;
BORCHARDT, RT .
LIFE SCIENCES, 1991, 49 (16) :1197-1206
[7]   CLONAL ANALYSIS OF SUCRASE ISOMALTASE EXPRESSION IN THE HUMAN COLON ADENOCARCINOMA CACO-2 CELLS [J].
BEAULIEU, JF ;
QUARONI, A .
BIOCHEMICAL JOURNAL, 1991, 280 :599-608
[8]   EVIDENCE FOR GLUCURONIDE CONJUGATION OF PARA-NITROPHENOL IN THE CACO-2 CELL MODEL [J].
BJORGE, S ;
HAMELEHLE, KL ;
HOMAN, R ;
ROSE, SE ;
TURLUCK, DA ;
WRIGHT, DS .
PHARMACEUTICAL RESEARCH, 1991, 8 (11) :1441-1443
[9]  
BOULENC X, 1992, J PHARMACOL EXP THER, V263, P1471
[10]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3